Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?
about
Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.Linking medicine and economics: health economics and quality of life in haemophilia care.Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.Home management of haemophilia.Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide.A comparison between prophylaxis and on demand treatment for severe haemophilia.Clinical outcomes and resource utilization associated with haemophilia care in Europe.Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.Recombinant factor concentrates may increase inhibitor development: a single centre cohort study.On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.Health status and health-related quality of life of children with haemophilia from six West European countries.Economic evaluation: what are we looking for and how do we get there?Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.Experience of prophylaxis treatment in children with severe haemophilia.
P2860
Q34094037-B9FC5E10-49FF-49DA-8834-6263F51E36D5Q34636921-FEA820E6-0D42-4761-A973-C160F77AD9F6Q35163649-7F6C2B27-7E59-4F0A-97AE-E8F36F876CF7Q35666730-B1019B09-11DE-463F-B308-860F659EB5C0Q35915662-2F3EE66F-2BA3-4C2E-9AE5-AB0627E980EBQ40386883-B628B7EC-C2C9-462A-AB28-80D2BFB25C3EQ40654709-F71B0641-3CBF-4ED6-B40C-506BDEC93A0FQ45855990-4627733E-B920-4568-AC8D-5EF2D917766BQ45866892-63243971-7497-478A-91E1-56276E35FBF5Q45868951-05471A6A-697A-4DE8-BF4D-B424C4F3D929Q45873268-88074928-6929-4B61-B773-EF2E63F89671Q45873277-B469AEBD-2B6E-405B-91B2-CCE3232C89F2Q45877768-7AC917C1-8322-4F6A-A858-584EEE2CD2EDQ45885096-6AAEF3D0-B4E5-4FE0-A14D-21F56F34E348
P2860
Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Primary prophylaxis for indivi ...... isits could treatment prevent?
@ast
Primary prophylaxis for indivi ...... isits could treatment prevent?
@en
type
label
Primary prophylaxis for indivi ...... isits could treatment prevent?
@ast
Primary prophylaxis for indivi ...... isits could treatment prevent?
@en
prefLabel
Primary prophylaxis for indivi ...... isits could treatment prevent?
@ast
Primary prophylaxis for indivi ...... isits could treatment prevent?
@en
P2093
P2860
P1476
Primary prophylaxis for indivi ...... isits could treatment prevent?
@en
P2093
P2860
P304
P356
10.1046/J.1365-2796.2000.00633.X
P407
P577
2000-04-01T00:00:00Z